Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiondynein intermediate chain binding

SPTBN5 DYNC2H1 DNAH5 DNAH7

1.23e-0537774GO:0045505
GeneOntologyMolecularFunctionminus-end-directed microtubule motor activity

DYNC2H1 DNAH5 DNAH7

4.32e-0518773GO:0008569
GeneOntologyMolecularFunctiondynein light intermediate chain binding

DYNC2H1 DNAH5 DNAH7

1.69e-0428773GO:0051959
GeneOntologyCellularComponentnuclear pore inner ring

NUP188 NUP205

4.22e-053792GO:0044611
GeneOntologyCellularComponentspectrin

SPTBN5 SPTA1

4.99e-049792GO:0008091
GeneOntologyCellularComponentdynein complex

DYNC2H1 DNAH5 DNAH7

1.12e-0354793GO:0030286
GeneOntologyCellularComponentaxoneme

SPTBN5 DYNC2H1 DNAH5 DNAH7 HYDIN

1.13e-03207795GO:0005930
GeneOntologyCellularComponentciliary plasm

SPTBN5 DYNC2H1 DNAH5 DNAH7 HYDIN

1.15e-03208795GO:0097014
GeneOntologyCellularComponentplasma membrane bounded cell projection cytoplasm

SPTBN5 DYNC2H1 LRRK2 DNAH5 DNAH7 HYDIN

1.27e-03317796GO:0032838
DomainVIT_2

VWA5B2 VWA5B1

1.63e-052762PF13757
DomainDynein_heavy_chain_D4_dom

DYNC2H1 DNAH5 DNAH7

2.28e-0514763IPR024317
DomainDynein_HC_stalk

DYNC2H1 DNAH5 DNAH7

2.28e-0514763IPR024743
DomainDynein_heavy_dom-2

DYNC2H1 DNAH5 DNAH7

2.28e-0514763IPR013602
DomainDHC_N2

DYNC2H1 DNAH5 DNAH7

2.28e-0514763PF08393
DomainMT

DYNC2H1 DNAH5 DNAH7

2.28e-0514763PF12777
DomainAAA_8

DYNC2H1 DNAH5 DNAH7

2.28e-0514763PF12780
DomainATPase_dyneun-rel_AAA

MDN1 DYNC2H1 DNAH5

2.28e-0514763IPR011704
DomainAAA_5

MDN1 DYNC2H1 DNAH5

2.28e-0514763PF07728
DomainDHC_fam

DYNC2H1 DNAH5 DNAH7

2.84e-0515763IPR026983
DomainDynein_heavy_dom

DYNC2H1 DNAH5 DNAH7

2.84e-0515763IPR004273
DomainDynein_heavy

DYNC2H1 DNAH5 DNAH7

2.84e-0515763PF03028
DomainDUF3338

FRMD4A FRMD4B

9.75e-054762PF11819
DomainDUF3338

FRMD4A FRMD4B

9.75e-054762IPR021774
DomainSpectrin

SPTBN5 KALRN SPTA1

1.08e-0423763PF00435
DomainSpectrin_repeat

SPTBN5 KALRN SPTA1

2.19e-0429763IPR002017
DomainSSX

SSX2 SSX3

2.43e-046762IPR028804
DomainSpectrin/alpha-actinin

SPTBN5 KALRN SPTA1

2.95e-0432763IPR018159
DomainSPEC

SPTBN5 KALRN SPTA1

2.95e-0432763SM00150
DomainPH_dom-like

SPTBN5 FRMD4A RASGRF2 KALRN PLEKHG4 OSBPL6 VPS36 FRMD4B

3.33e-04426768IPR011993
DomainSSXRD

SSX2 SSX3

4.50e-048762PF09514
DomainSSXRD_motif

SSX2 SSX3

4.50e-048762IPR019041
DomainVWA_3

VWA5B2 VWA5B1

4.50e-048762PF13768
DomainDHC_N1

DYNC2H1 DNAH5

4.50e-048762PF08385
DomainDynein_heavy_dom-1

DYNC2H1 DNAH5

4.50e-048762IPR013594
DomainVIT

VWA5B2 VWA5B1

7.20e-0410762PS51468
DomainVIT

VWA5B2 VWA5B1

7.20e-0410762IPR013694
Domain-

MDN1 DYNC2H1 DHX40 LRRK2 IFI44 DNAH5 DNAH7 HYDIN ARL5A MX1

8.57e-0474676103.40.50.300
DomainKRAB_RELATED

SSX2 SSX3

8.78e-0411762PS50806
Domain-

SPTBN5 FRMD4A RASGRF2 KALRN PLEKHG4 OSBPL6 FRMD4B

1.06e-033917672.30.29.30
DomainKrueppel-associated_box-rel

SSX2 SSX3

1.24e-0313762IPR003655
DomainDH_1

RASGRF2 KALRN PLEKHG4

2.16e-0363763PS00741
DomainP-loop_NTPase

MDN1 DYNC2H1 DHX40 LRRK2 IFI44 DNAH5 DNAH7 HYDIN ARL5A MX1

2.23e-038487610IPR027417
DomainPH

SPTBN5 RASGRF2 KALRN PLEKHG4 OSBPL6

2.42e-03229765PF00169
DomainBRCT

PARP1 NBN

2.67e-0319762PF00533
DomainRhoGEF

RASGRF2 KALRN PLEKHG4

2.68e-0368763SM00325
DomainAAA+_ATPase

MDN1 DYNC2H1 DNAH5 DNAH7

2.83e-03144764IPR003593
DomainAAA

MDN1 DYNC2H1 DNAH5 DNAH7

2.83e-03144764SM00382
DomainRhoGEF

RASGRF2 KALRN PLEKHG4

2.91e-0370763PF00621
DomainDH_2

RASGRF2 KALRN PLEKHG4

2.91e-0370763PS50010
DomainDH-domain

RASGRF2 KALRN PLEKHG4

3.03e-0371763IPR000219
Domain-

RASGRF2 KALRN PLEKHG4

3.03e-03717631.20.900.10
DomainEz/rad/moesin-like

FRMD4A FRMD4B

3.26e-0321762IPR000798
DomainBRCT

PARP1 NBN

3.58e-0322762SM00292
Domain-

PARP1 NBN

3.91e-03237623.40.50.10190
DomainFERM_CS

FRMD4A FRMD4B

4.26e-0324762IPR019747
DomainFERM_C

FRMD4A FRMD4B

4.99e-0326762PF09380
DomainBRCT

PARP1 NBN

4.99e-0326762PS50172
DomainFERM_C

FRMD4A FRMD4B

5.37e-0327762SM01196
DomainFERM_PH-like_C

FRMD4A FRMD4B

5.37e-0327762IPR018980
DomainPH

SPTBN5 RASGRF2 KALRN PLEKHG4 OSBPL6

5.51e-03278765SM00233
Pubmed

Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.

DYNC2H1 DNAH5 DNAH7

4.03e-06147939373155
Pubmed

p63 directly induces expression of Alox12, a regulator of epidermal barrier formation.

TP63 ALOX12

5.09e-06279219555433
Pubmed

Dematin interacts with the Ras-guanine nucleotide exchange factor Ras-GRF2 and modulates mitogen-activated protein kinase pathways.

RASGRF2 SPTA1

1.53e-05379211856323
Pubmed

ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion.

FAT2 TP63

1.53e-05379227081041
Pubmed

SSX2-4 expression in early-stage non-small cell lung cancer.

SSX2 SSX3

1.53e-05379224645645
Pubmed

PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites.

PARP1 NBN

1.53e-05379218025084
Pubmed

ΔNp63 controls a TLR3-mediated mechanism that abundantly provides thymic stromal lymphopoietin in atopic dermatitis.

TP63 TLR3

1.53e-05379225171086
Pubmed

Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha).

TP63 TLR3

1.53e-05379221367858
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

PARP1 FAT2 MDN1 DHX40 SNX25 DNAH5

1.60e-0523479636243803
Pubmed

Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.

SSX2 SSX3

3.05e-05479210749136
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

ARFGEF3 DYNC2H1 DHX40 CDK11A NBN AASDH TOP3A VCPIP1

5.79e-0558879838580884
Pubmed

Architecture of the linker-scaffold in the nuclear pore.

NUP188 NUP205

7.60e-05679235679425
Pubmed

Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

DNAH7 POFUT2 FRMD4B FAN1

8.85e-0510279410231032
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

PARP1 TBC1D31 MDN1 DNAJC10 ZNF789 SNX25 SPTA1 ASH1L CCDC150 VPS36 POFUT2 NUP205

9.65e-051442791235575683
Pubmed

Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome.

NUP188 NUP205

1.06e-04779226878725
Pubmed

Redistribution of BRCA1 among four different protein complexes following replication blockage.

NBN MED17

1.06e-04779211504724
Pubmed

p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia.

TP63 UPK3B

1.06e-04779223620512
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

PARP1 TLR3 LRRK2 DNAH5 VCPIP1

1.15e-0420879533230847
Pubmed

The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP.

SSX2 SSX3

1.41e-04879212007189
Pubmed

FRMD4A regulates epithelial polarity by connecting Arf6 activation with the PAR complex.

FRMD4A FRMD4B

1.41e-04879220080746
Pubmed

p63-dependent and independent mechanisms of nectin-1 and nectin-4 regulation in the epidermis.

TP63 AFDN

1.82e-04979225387952
Pubmed

Type-I-interferon-responsive microglia shape cortical development and behavior.

TLR3 MX1

1.82e-04979238490196
Pubmed

PTEN identified as important risk factor of chronic obstructive pulmonary disease.

PARP1 TP63 NBN CASR ALOX12 MX1

2.13e-0437479619625176
Pubmed

Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.

PARP1 TP63 NBN CASR ALOX12 MX1

2.36e-0438179618676680
Pubmed

Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.

PARP1 TP63 NBN CASR ALOX12 MX1

2.39e-0438279619170196
Pubmed

Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner.

TLR3 MX1

3.31e-041279229632368
Pubmed

The mouse homeobox gene Noto regulates node morphogenesis, notochordal ciliogenesis, and left right patterning.

DYNC2H1 DNAH5

3.91e-041379217884984
Pubmed

Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.

TPO KALRN

3.91e-041379224586183
Pubmed

Interplay between Caspase 9 and X-linked Inhibitor of Apoptosis Protein (XIAP) in the oocyte elimination during fetal mouse development.

PARP1 TP63

3.91e-041379231624230
Pubmed

Genetic susceptibility to distinct bladder cancer subphenotypes.

PARP1 TP63 NBN CASR ALOX12 MX1

4.01e-0442179619692168
Pubmed

Identification of potential protein interactors of Lrrk2.

MDN1 LRRK2

5.25e-041579217400507
Pubmed

Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia.

PARP1 NBN

5.25e-041579220232390
Pubmed

Brg1 determines urothelial cell fate during ureter development.

TP63 UPK3B

5.99e-041679223449535
Pubmed

Stalled replication forks within heterochromatin require ATRX for protection.

PARP1 NBN

5.99e-041679227171262
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

MDN1 DYNC2H1 DHX40 NBN MED17 DNAH7 AKR7A2

6.26e-0463879731182584
Pubmed

Interferon Regulatory Factor 6 Is Necessary for Salivary Glands and Pancreas Development.

TPO TP63

6.78e-041779228898113
Pubmed

DeltaNp63 plays an anti-apoptotic role in ventral bladder development.

TP63 UPK3B

6.78e-041779217079275
Pubmed

Fibroproliferative response to urothelial failure obliterates the ureter lumen in a mouse model of prenatal congenital obstructive nephropathy.

PARP1 TP63

6.78e-041779227511831
Pubmed

The C-terminal domain of TAP interacts with the nuclear pore complex and promotes export of specific CTE-bearing RNA substrates.

NUP188 NUP205

6.78e-041779210668806
Pubmed

TP63 gain-of-function mutations cause premature ovarian insufficiency by inducing oocyte apoptosis.

PARP1 TP63

6.78e-041779236856110
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

TBC1D31 CEP120 DHX40 NBN AFDN DNAH7 VCPIP1 NUP205

7.12e-0485379828718761
Pubmed

Probing nuclear pore complex architecture with proximity-dependent biotinylation.

AFDN NUP188 NUP205

7.31e-047779324927568
Pubmed

Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease.

SPTBN5 SPTA1

7.61e-041879212119179
Pubmed

Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription.

PARP1 MED17

8.50e-041979216204234
Pubmed

Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.

SPTBN5 DNAJC10 DYNC2H1 SPTA1

8.88e-0418779426460568
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

MDN1 DNAJC10 RASGRF2 CDK11A VPS36 HYDIN

9.52e-0449779636774506
Pubmed

ETAA1 acts at stalled replication forks to maintain genome integrity.

PARP1 TOP3A

1.04e-032179227723720
Pubmed

The SSX gene family: characterization of 9 complete genes.

SSX2 SSX3

1.04e-032179212216073
Pubmed

Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.

PARP1 TP63 MED17

1.08e-038879326318153
Pubmed

The RNF146 and tankyrase pathway maintains the junctional Crumbs complex through regulation of angiomotin.

AFDN FRMD4B

1.14e-032279227521426
Pubmed

A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers.

PARP1 KALRN

1.36e-032479216620772
Pubmed

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

ANKRD13D SPTBN5 STEAP3 DNAH5

1.46e-0321479422199357
Pubmed

DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.

PARP1 NBN

1.48e-032579220150366
Pubmed

Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.

DYNC2H1 DNAH5

1.48e-032579227340223
Pubmed

Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.

SPTBN5 SPTA1

1.48e-03257928493579
Pubmed

SSRI treatment modifies the effects of maternal inflammation on in utero physiology and offspring neurobiology.

TLR3 MX1

1.48e-032579236343752
Pubmed

Control of TurboID-dependent biotinylation intensity in proximity ligation screens.

STX17 POFUT2 VCPIP1

1.56e-0310079336966971
Pubmed

Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.

PARP1 NBN

1.60e-032679220731661
Pubmed

The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation.

TLR3 IFI44

1.60e-032679238744293
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

MDN1 DHX40 CDK11A NBN

1.67e-0322279437071664
Pubmed

The MEV mouse linkage testing stock: mapping 30 novel proviral insertions and establishment of an improved stock.

TPO SPTA1

1.72e-03277928390965
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

ARFGEF3 LRRK2 STEAP3 INSM2 AFDN DNAH7 ARL5A

1.95e-0377779735844135
Pubmed

TopBP1 controls BLM protein level to maintain genome stability.

PARP1 TOP3A

1.99e-032979224239288
Pubmed

Defining the human deubiquitinating enzyme interaction landscape.

PARP1 TRMT2A DYNC2H1 DHX40 NUP188 POFUT2 VCPIP1 NUP205

2.02e-03100579819615732
Pubmed

The Catalytically Inactive Mutation of the Ubiquitin-Conjugating Enzyme CDC34 Affects its Stability and Cell Proliferation.

PARP1 MDN1 DNAJC10 NUP205

2.12e-0323779429564676
Pubmed

Integrated structural analysis of the human nuclear pore complex scaffold.

NUP188 NUP205

2.13e-033079224315095
Pubmed

Isolation and characterization of proteins associated with histone H3 tails in vivo.

PARP1 ASH1L

2.13e-033079217403666
Pubmed

Upregulation of μ3A Drives Homeostatic Plasticity by Rerouting AMPAR into the Recycling Endosomal Pathway.

DYNC2H1 FAN1

2.13e-033079227568566
Pubmed

The Structure Inventory of the Nuclear Pore Complex.

NUP188 NUP205

2.13e-033079227016207
Pubmed

Conditional ablation of the Notch2 receptor in the ocular lens.

PARP1 TP63

2.27e-033179222173065
Cytoband2q32.1

DNAJC10 OSBPL6

1.23e-03307922q32.1
Cytoband22q11.1

XKR3 POTEH

1.77e-033679222q11.1
GeneFamilyEF-hand domain containing|Spectrins

SPTBN5 SPTA1

1.96e-0475621113
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

RASGRF2 KALRN PLEKHG4

1.12e-0366563722
GeneFamilyDyneins, axonemal

DNAH5 DNAH7

1.24e-0317562536
CoexpressionPEDRIOLI_MIR31_TARGETS_DN

ANKRD35 FAT2 CEP120 MDN1 RASGRF2 OSBPL6 AFDN NUP188 MX1 VCPIP1

4.10e-074137810M2494
CoexpressionGSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP

VWA5B2 DYNC2H1 KRT222 IFI44 TOP3A MX1 NUP205

2.19e-06199787M9759
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ARFGEF3 DYNC2H1 SNX25 LRRK2 OSBPL6 DNAH5 DNAH7 HYDIN

1.99e-09193798bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LRRK2 AFDN CASR DNAH5 DNAH7 HYDIN

1.27e-06194796e577d9e88390b36b5a09b97fe1026089892275a3
ToppCellIPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class

ARFGEF3 DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

1.31e-06195796fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCellIPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class

ARFGEF3 DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

1.31e-0619579621dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCellIPF-Multiplet|IPF / Disease state, Lineage and Cell class

ARFGEF3 DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

1.31e-06195796eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

VWA5B2 DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

1.39e-0619779674a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCellBiopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type

ST6GALNAC1 ARFGEF3 DYNC2H1 DNAH5 DNAH7 HYDIN

1.52e-0620079676f1ac00b34d07057d8da03d276438b719b46b1d
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb-Excitatory_Neuron.Sc17a7.Rorb-BC006965_(Layer_5a,_BC006965+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

TPO CCDC83 GDF3 HYDIN

1.32e-05817949de04f435b5acbfb1d709103db35e56e8ac97a85
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

1.42e-05173795c3762655caa79ac4879876f470d32578a3c93b01
ToppCell343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

CEP120 TRMT2A KALRN PLEKHG4 TTL

1.46e-05174795a1f745962a104c6f4b86b7e482da8755384c773a
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 AFDN DNAH5 DNAH7 HYDIN

1.72e-0518079592fb01b91261b3103454924cde56add337b41844
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARFGEF3 KALRN SPTA1 DNAH5 HYDIN

1.91e-051847952cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARFGEF3 KALRN SPTA1 DNAH5 HYDIN

1.91e-05184795ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARFGEF3 KALRN SPTA1 DNAH5 HYDIN

1.91e-051847952b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellCiliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

1.96e-05185795f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ARFGEF3 XKR3 SNX25 LRRK2 DNAH5

2.01e-051867952ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.07e-05187795e61992de4f98eeea08b43213850769d923f8db48
ToppCell21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.12e-05188795803bf76a85b3033d2a04b08dd2c03ce9c15529ba
ToppCellCOVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type

ST6GALNAC1 ARFGEF3 FAT2 TP63 DNAH5

2.17e-0518979584d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

LRRK2 CASR DNAH5 DNAH7 HYDIN

2.23e-051907953fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCellCOVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type

TPO RASGRF2 KALRN IFI44 FRMD4B

2.23e-0519079578e7c502b0450c0b37652b1896a2a752fd8a2111
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

ARFGEF3 OSBPL6 DNAH5 DNAH7 HYDIN

2.29e-051917957b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ARFGEF3 OSBPL6 DNAH5 DNAH7 HYDIN

2.29e-05191795fa9f8b50bfc7911c858bc2f9dcd204873d97ac61
ToppCellControl-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class

ARFGEF3 OSBPL6 DNAH5 DNAH7 HYDIN

2.29e-05191795ea1d2c6838119b7019e9a2ff71d6212262b51b57
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ARFGEF3 OSBPL6 DNAH5 DNAH7 HYDIN

2.29e-05191795b4e335e798c9617356b8e24412f9270c42dce656
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ARFGEF3 OSBPL6 DNAH5 DNAH7 HYDIN

2.29e-05191795c4b223b33c020a064f576711a3d700eb60a2d737
ToppCellControl-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30）

ARFGEF3 OSBPL6 DNAH5 DNAH7 HYDIN

2.29e-05191795cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12
ToppCellControl-Epithelial|Control / Condition, Lineage and Cell class

ARFGEF3 OSBPL6 DNAH5 DNAH7 HYDIN

2.29e-051917956228302febdb3dffe37dece7062d27ac9ccc6d4b
ToppCellCOVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type

ST6GALNAC1 ARFGEF3 FAT2 TP63 DNAH5

2.34e-0519279559261098ccb52306f837f632ebaea45b90ad30fe
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.40e-05193795e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCellNS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DYNC2H1 STEAP3 DNAH5 DNAH7 HYDIN

2.40e-05193795ea345d34440b25f65358a53dc72831998d1c3620
ToppCell15-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.40e-05193795aa3acc7571405169efb656d214f3a8cbf988362e
ToppCellnucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ARFGEF3 SNX25 LRRK2 AFDN DNAH5

2.52e-051957959406866f99555198a9be311fbd65751b70f35446
ToppCellCOVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type

TPO RASGRF2 KALRN IFI44 AFDN

2.52e-0519579550a193475db1bb1e05b8590225a553688c372c14
ToppCellBL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.52e-0519579507a6bcef6af93ed87df455dee624037cb75e011a
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.59e-05196795a37ba02446eef5d1fab703204583f6550a8ec3e1
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.59e-05196795a156840330630e518bc85633dded6f2c3ead3b30
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.59e-05196795009e83c7251cf300be78b263634d233a8d972a68
ToppCell3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.59e-0519679589ea4d2086e1c769c5a87f1471a6cd4acabcfe33
ToppCellIPF-Epithelial|IPF / Disease state, Lineage and Cell class

ARFGEF3 DYNC2H1 DNAH5 DNAH7 HYDIN

2.59e-0519679587d9881cfec461a5d89b688a83749b618c519485
ToppCellPSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.65e-051977956865f4831eb23794fb88a8649d48d497bbae3f44
ToppCellAT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

ARFGEF3 TMEM178A TP63 SNX25 LRRK2

2.65e-05197795fd7bdfa6bf5966ebc11fdd13915769429540ddbf
ToppCellLPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type

ST6GALNAC1 UPK3B DNAH5 DNAH7 HYDIN

2.72e-05198795e035380578c01b0243bfef29ca9b50cc17cce771
ToppCellLPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type

ST6GALNAC1 UPK3B DNAH5 DNAH7 HYDIN

2.72e-05198795ba090210392e001a3f7bdf09371b3f0e0c8c7ef3
ToppCellBAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ST6GALNAC1 ARFGEF3 DNAH5 DNAH7 HYDIN

2.78e-051997951ee4010d8557564e25e8ee00b914c2dfd9037838
ToppCellBAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

ST6GALNAC1 ARFGEF3 DNAH5 DNAH7 HYDIN

2.78e-051997951df69c0cb5f759f6a2152521842506a75bb95cae
ToppCellLPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type

ST6GALNAC1 ARFGEF3 TP63 UPK3B DNAH5

2.78e-05199795165ac94b2d56072ad43358b5127d77555221e2d8
ToppCellMild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass

ST6GALNAC1 ARFGEF3 DNAH5 DNAH7 HYDIN

2.78e-0519979581115bbd2c10bfdd38376d2075f03a59c31870d2
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ARFGEF3 DYNC2H1 OSBPL6 DNAH5 HYDIN

2.78e-0519979592fdf6e2f0786ab2ab78126e9131a93794168139
ToppCellBAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ST6GALNAC1 ARFGEF3 DNAH5 DNAH7 HYDIN

2.78e-0519979574087b4b5e567310fc4ac58fb267ff651a180680
ToppCellBAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

ST6GALNAC1 ARFGEF3 DNAH5 DNAH7 HYDIN

2.78e-0519979500b5ce099c50a5e1786ce2b3a06ee0931a8205a4
ToppCellMild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass

ST6GALNAC1 ARFGEF3 DNAH5 DNAH7 HYDIN

2.78e-05199795ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18
ToppCellMild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass

ST6GALNAC1 ARFGEF3 DNAH5 DNAH7 HYDIN

2.78e-0519979591308b255783ad4029e5575028c18d7550832c51
ToppCellMild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）

ST6GALNAC1 ARFGEF3 DNAH5 DNAH7 HYDIN

2.78e-0519979572689bda7476930887ae007682fcab27f956f050
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.85e-05200795cc906ff02fd335ff633b3b97afceb670494f910a
ToppCellLPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ST6GALNAC1 TP63 DNAH5 DNAH7 HYDIN

2.85e-05200795cf191104484bfb2b9f87de416b9453135f8833c1
ToppCellBiopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.85e-05200795bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8
ToppCellLPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ST6GALNAC1 TP63 DNAH5 DNAH7 HYDIN

2.85e-05200795a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607
ToppCellBrain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Neuron|5w / Sample Type, Dataset, Time_group, and Cell type.

VWA5B2 SPTBN5 TMEM178A STEAP3 INSM2

2.85e-052007956f3fe94107fa2a2ded4888780b36700cce48adb7
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 OSBPL6 DNAH5 DNAH7 HYDIN

2.85e-05200795873def69bf55ccbfc944bc10c5afc06be019c312
ToppCellControl-CD4+_T_activated|Control / Disease condition and Cell class

TMEM178A IFI44 DNAH5 MX1

5.43e-05116794e3d1a90a229f5697b2b715574bb96790a435f73b
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

TMEM178A IFI44 DNAH5 MX1

5.80e-05118794f76fc6db7368a1e8e5e4f8535fc3dc78afe13b9b
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TMEM178A IFI44 DNAH5 MX1

5.80e-051187940dcac16eea8e7978de370a815da9a0cdd212598e
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TMEM178A IFI44 DNAH5 MX1

5.80e-051187947da3957d102e9f9825fc2609d6d0bd9ca6a3fba4
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TMEM178A IFI44 DNAH5 MX1

5.80e-05118794c5c6724e0e526d7c2fc8cabff4a112a900ec997f
ToppCellControl-Lymphoid_T/NK-CD4+_T_activated|Control / Disease group, lineage and cell class

TMEM178A IFI44 DNAH5 MX1

6.00e-05119794d7352d0dafbb664619b7a1e3cd07b159fdfec197
ToppCellhealthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|healthy_donor / Disease condition, Lineage, Cell class and subclass

RASGRF2 IFI44 DNAH5 MX1

1.07e-0413879497f5dc17522462133e582b508ad0ef036e656872
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Dditl_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

C17orf67 BAAT KLB

1.08e-0452793f72bbaf941a1e499a25a54bf1da51d960df946e8
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th-Slc17a6-Lpl_(VTA_(ventral_VTA))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CCDC83 CASR GDF3

1.15e-0453793605cd3214c1c17a11b69ca65b44c4a3a322f3fbb
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th-Slc17a6-Lpl_(VTA_(ventral_VTA))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CCDC83 CASR GDF3

1.15e-0453793e7f69a8b4dab2d63da84b7aaa7e192c8e19a06ad
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Cdkn1c_(Cdkn1c)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

UPK3B IFI44 ALOX12

1.21e-045479369f66fe78fd59c44b6ca6b565df0ea8e035121e1
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Cdkn1c_(Cdkn1c)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

UPK3B IFI44 ALOX12

1.21e-045479375dd172b298d3fb81f3e0c82f593772cb3487b62
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Cdkn1c_(Cdkn1c)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

UPK3B IFI44 ALOX12

1.21e-045479367cc62761906a29e9f7beb03b74f600e516c47f1
ToppCell343B-Lymphocytic-NK_cells-NK_cell_E|343B / Donor, Lineage, Cell class and subclass (all cells)

CEP120 TRMT2A KALRN PLEKHG4

1.75e-041577940362c04b7b0b5017964b3a73ee678ae53e7238d7
ToppCellCiliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

DYNC2H1 DNAH5 DNAH7 HYDIN

2.07e-04164794fd30c55d0d75ef8b9396435d836187168095152b
ToppCell3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWA5B2 ARFGEF3 TMEM178A HYDIN

2.16e-04166794d96c562e1483adb4cdd817b68133f03356d7279b
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Nfib-Inhibitory_Neuron.Gad1Gad2.Nfib-Satb1_(Supramammillary_Nucleus_(SuM))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SPTBN5 TEX38 TMEM253

2.20e-0466793f7d1d272ae723d8100b8c252b3d894dae5297fe4
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Nfib|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SPTBN5 TEX38 TMEM253

2.20e-04667932180e189dad1347ad77733ea95a934d70be97ee4
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Nfib-Inhibitory_Neuron.Gad1Gad2.Nfib-Satb1_(Supramammillary_Nucleus_(SuM))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

SPTBN5 TEX38 TMEM253

2.20e-0466793412c95c708344fd1726351389bb8a3d376f54fe4
ToppCelllung-Ciliated_Epithelia|lung / shred on tissue and cell subclass

DYNC2H1 OSBPL6 DNAH5 DNAH7

2.21e-0416779426cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 OSBPL6 DNAH7 HYDIN

2.32e-04169794fba841664939c771881ba97f14ef1df6635c04ff
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DYNC2H1 DNAH5 DNAH7 HYDIN

2.32e-0416979414aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPO SPTA1 DNAH5 HYDIN

2.32e-0416979412bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCellfacs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KALRN DYNC2H1 NUP188 TOP3A

2.37e-04170794d70aaa0f4e5034bb9f61b832b5f9123870936d3c
ToppCellCiliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

ST6GALNAC1 VWA5B2 DNAH5 HYDIN

2.37e-041707948b7ef1464ea589886b575ebad5447b085cbdcdba
ToppCellPND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANKRD35 KALRN SPTA1 ALOX12

2.48e-04172794e39ea2f4edbf36ebf9604fa6f9349081859c596c
ToppCellCiliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

DYNC2H1 DNAH5 DNAH7 HYDIN

2.48e-04172794187ae91148d293537afc77e10da2b64302322224
ToppCellPND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANKRD35 KALRN SPTA1 ALOX12

2.48e-04172794875ea290840e835952623b905eb610f3c71456d2
ToppCellPND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANKRD35 KALRN SPTA1 ALOX12

2.48e-04172794bcc50bed47465daa953ba91f17d1ee4c947ab461
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

TPO CCDC83 DNAH5

2.51e-04697931592edde44c3927d6a2350eb00f92c10d3adf692
ToppCell5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWA5B2 CCDC83 CASR KLB

2.59e-041747949f114e61458659005b6d0b4aa30a7a059e7aa5c6
ToppCellPND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KALRN SPTA1 CCDC150 ALOX12

2.59e-04174794a3f4981b10afa9d41a1c66c7f98522a8a534f82b
ToppCellPND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KALRN SPTA1 CCDC150 ALOX12

2.59e-041747946cc108dde4b3f98a78a6040280f0d5e4aaa5bd75
ToppCellPND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KALRN SPTA1 CCDC150 ALOX12

2.59e-041747944b8bc5568e36031c8ecf001bb646809038c23919
ToppCell5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

VWA5B2 CCDC83 CASR KLB

2.65e-04175794182e45f5c02214d6b9f317ff5dc43af8b42de978
ToppCell343B-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

CEP120 TRMT2A KALRN PLEKHG4

2.65e-0417579478a86cac3e6c0d115c997d1c29ee0e24af54551f
ToppCellfacs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C17orf67 IFI44 DNAH5 HYDIN

2.70e-041767940b3491451be02c18a16cdb875645be47eb867a7f
ToppCellAdult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor

ST6GALNAC1 ARFGEF3 CASR DNAH5

2.76e-04177794d652b7d84fe6aa38319d8d5adc72c70441bd0088
ToppCellSevere-CD4+_T_activated|World / Disease group and Cell class

ST6GALNAC1 TLR3 FRMD4B MX1

2.82e-04178794ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCellPND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANKRD35 KALRN SPTA1 ALOX12

2.82e-041787949e1f2596fcea5b79cc50b58d83706bb8605e224f
Drug6-propionyl-2-(dimethylamino)naphthalene

SPTBN5 PLEKHG4 TP63 SPTA1

2.25e-0716784CID000107729
Diseasedisease of metabolism (is_implicated_in)

BAAT NBN

8.75e-056722DOID:0014667 (is_implicated_in)
DiseaseHuman papillomavirus infectious disease (is_marker_for)

TLR3 MX1

2.61e-0410722DOID:11166 (is_marker_for)
DiseaseJeune thoracic dystrophy

CEP120 DYNC2H1

3.18e-0411722C0265275
DiseaseShort Rib-Polydactyly Syndrome

CEP120 DYNC2H1

4.50e-0413722C0036996
DiseaseSaldino-Noonan Syndrome

CEP120 DYNC2H1

5.24e-0414722C0036069
DiseaseMajewski Syndrome

CEP120 DYNC2H1

5.24e-0414722C0024507
Diseaseperinatal necrotizing enterocolitis (biomarker_via_orthology)

PARP1 TLR3

7.80e-0417722DOID:8677 (biomarker_via_orthology)
DiseaseAutosomal Dominant Parkinsonism

PARP1 LRRK2

2.13e-0328722C0752098
DiseaseAutosomal Dominant Juvenile Parkinson Disease

PARP1 LRRK2

2.13e-0328722C0752097
DiseaseParkinsonism, Experimental

PARP1 LRRK2

2.13e-0328722C0752101
DiseaseAutosomal Recessive Parkinsonism

PARP1 LRRK2

2.13e-0328722C0752100
DiseaseFamilial Juvenile Parkinsonism

PARP1 LRRK2

2.13e-0328722C0752104
DiseaseRamsay Hunt Paralysis Syndrome

PARP1 LRRK2

2.13e-0328722C0242423
DiseasePARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE

PARP1 LRRK2

2.13e-0328722C1868675

Protein segments in the cluster

PeptideGeneStartEntry
RKLADIIHHWNANRL

AFDN

11

P55196
IIHHWNANRLDLFEI

AFDN

16

P55196
EHAWKEIQRFLRKHL

BAAT

396

Q14032
RNRFWKEHHFEAIAL

AKR7A2

261

O43488
LKHHVFLVRNWEKIR

ASH1L

2361

Q9NR48
HRLVWANRHRELEAA

ANKRD13D

11

Q6ZTN6
TRIWRLFNHQEHKVI

ARL5A

6

Q9Y689
EAWQVLKHLRHLNFT

CASR

456

P41180
HNDLVLFRLHWKNTE

AASDH

136

Q4L235
RWNRHDQKLLEAVHR

ANKRD35

16

Q8N283
ALHTQDKALWRHLQQ

ANKRD35

226

Q8N283
NSRLKEEQIWHIRHL

CCDC83

61

Q8IWF9
FKQLHNRRLLWHGSR

PARP1

851

P09874
LHAKRHALESWRQLV

NUP205

1276

Q92621
LRDKTRWTQNFHHFL

MAP4K2

236

Q12851
QELRDLWSLLHHQKV

MDN1

2986

Q9NU22
LFLLLQHWRQGKHRT

LILRB4

276

Q8NHJ6
RHQLFINFRDLGWHK

GDF3

266

Q9NR23
DHWRNLQRFLSHKLD

FAT2

3646

Q9NYQ8
AQAELKEARRQWHHL

KRT222

51

Q8N1A0
LHTLWLREHNRLAAA

TPO

406

P07202
LLEFHIQKQLIRHRW

FAM205A

591

Q6ZU69
LLEFHIQKQSIRHRW

FAM205BP

321

Q63HN1
QVKDLEEHWQRHLAR

EVI5

531

O60447
LESIWQHRKVRLHQR

KALRN

521

O60229
HWKSLNLRELLFSHN

LRRK2

1216

Q5S007
RDFNSELLRLRQHWK

MED17

181

Q9NVC6
DLGLLQFVRLRKHHW

ALOX12

56

P18054
QFVRLRKHHWLVDDA

ALOX12

61

P18054
EKHRLWHAVREELLL

INSM2

486

Q96T92
AWVSKLRHHRLYRQN

OSBPL6

171

Q9BZF3
EQFRHAIWKGILDHR

TP63

591

Q9H3D4
AIWKGILDHRQLHEF

TP63

596

Q9H3D4
HLNWLQLDRRVLEHD

FRMD4A

71

Q9P2Q2
QNWLQLDHRVLDHDL

FRMD4B

111

Q9Y2L6
LFRRLSAVLHQHKEW

DYNC2H1

846

Q8NCM8
IHNRSNIIAHFLWKV

HYDIN

321

Q4G0P3
HSQEKFTRLNHFRWI

HYDIN

2731

Q4G0P3
RLTWLHEKILQNHFG

IFI44

6

Q8TCB0
AHRWFKHRFDGLQLE

CCDC150

1031

Q8NCX0
LAWEIDRKALHQHRL

CEP120

56

Q8N960
MHLHRRFTDLIWKNL

ARFGEF3

246

Q5TH69
LEHRAEEQFLEHWLN

C17orf67

61

Q0P5P2
LLHERAINKAEWRFL

DNAH7

3291

Q8WXX0
LHDNWILHRDLKTSN

CDK11A

541

Q9UQ88
AAHNLLVAHALAWRL

KLB

711

Q86Z14
AEWKREILRHHVNRN

CXorf38

81

Q8TB03
NTLEDRLAHHRWLLF

DNAJC10

356

Q8IXB1
ENNRLYHKLALHWKL

CHIC1

181

Q5VXU3
WVRDLLPKLHEFNAH

DHX40

691

Q8IX18
LFHRAWLRQIEEIHV

DNAH5

676

Q8TE73
RWWDRLALNLHQHLK

FAN1

706

Q9Y2M0
NRALLPWLLEQRHKH

TRMT2A

206

Q8IZ69
NHLHLWCLEARQLFR

TBC1D31

236

Q96DN5
HHARKNTELEEWLRQ

NBN

711

O60934
VHLRRKDFIWGHRQD

POFUT2

291

Q9Y2G5
DISHLLWRQAVHNKE

PLEKHG4

1021

Q58EX7
LEDFWEIARQLHHRL

SNX25

36

Q9H3E2
VLRHWVSKHAQDFEL

RASGRF2

921

O14827
KTIQQDEWHLLHLRR

TMEM178A

161

Q8NBL3
EHAWTHRLRERKQLV

SSX3

161

Q99909
NHDFKLEREVWKRLH

ST6GALNAC1

566

Q9NSC7
LREHQDLLEEIHLWQ

SPTBN5

1141

Q9NRC6
FAQWDQLVAHKRVHV

REPIN1

186

Q9BWE0
DLQHNNLARLWKHAN

TLR3

536

O15455
LLSTHRLIWRDQKNH

VPS36

41

Q86VN1
EHAWTHRLRERKQLV

SSX2

161

Q16385
DHWLQHRKQIGLLSF

STEAP3

296

Q658P3
RIWDKLHEEHINAGR

STX17

46

P56962
HRAAIAFLHALWQDR

NUP188

981

Q5SRE5
QLEQLKEHWDHLLER

SPTA1

1581

P02549
FNLRRHERTHLGEKW

ZNF705EP

241

A8MWA4
RELFWHALRENLKQH

VCPIP1

231

Q96JH7
HKDGIVEFNWKRHRL

TOP3A

276

Q13472
VEFNWKRHRLFNHTA

TOP3A

281

Q13472
ERHSLRLEKLQHWAR

TMEM253

11

P0C7T8
VWFLQRRFHKDILLN

VWA5B2

316

Q8N398
KRFAQWSHLAQHQLL

ZNF689

436

Q96CS4
DLRRNKAALLFWHIL

XKR3

91

Q5GH77
DPRIHRHLARAAKWQ

UPK3B

211

Q9BT76
HVRREDLDKLHRAAW

POTEH

171

Q6S545
HRKFDIRSWVLVDHQ

TTL

196

Q8NG68
LHWRKNLRREEHAQQ

TEX38

36

Q6PEX7
AFVWKSNLIRHQRIH

ZNF662

256

Q6ZS27
RRKAWFDQHQRIHFL

ZNF789

211

Q5FWF6
KAAARQLFVLLRHWD

VWA5B1

1191

Q5TIE3
RLRHEFHKWSTIIEN

MX1

406

P20591